StonvexLoading…
StonvexStonvexStonvexCore line items from CNXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $9.83B | $9.62B | $7.11B | $6.32B |
Operating Income | $-918.18M | $596.39M | $661.33M | $640.19M |
Net Income | $-1.28B | $251.22M | $313.84M | $435.05M |
EPS (Diluted) | $-20.36 | $3.71 | $5.70 | $8.28 |
Total Assets | $10.76B | $11.99B | $12.49B | $6.67B |
Total Liabilities | $8.02B | $7.95B | $8.35B | $3.97B |
Cash & Equivalents | $327.35M | $240.57M | $295.34M | $145.38M |
Free Cash Flow OCF − CapEx | $572.47M | $428.73M | $497.48M | $460.70M |
Shares Outstanding | 61.74M | 64.24M | 65.73M | 51.10M |